mirtazapine has been researched along with Ambulation Disorders, Neurologic in 3 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our patient was a 49-year-old Japanese woman with a history of depression; she was found in an unconscious state after ingesting boric acid (unknown amount), mirtazapine (1950 mg), and sennosides (780 mg)." | 3.91 | Cardiac arrest induced by the intentional ingestion of boric acid and mirtazapine treated by percutaneous cardiopulmonary bypass: a case report. ( Matsukawa, T; Nagasawa, H; Nakanishi, H; Saito, K; Yanagawa, Y; Yokoyama, K, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nagasawa, H | 1 |
| Nakanishi, H | 1 |
| Saito, K | 1 |
| Matsukawa, T | 1 |
| Yokoyama, K | 1 |
| Yanagawa, Y | 1 |
| Welsh, L | 1 |
| Binder, W | 1 |
| Miller, ES | 1 |
| Rath, T | 1 |
| Hackenbroch, M | 1 |
| Saech, J | 1 |
| Hallek, M | 1 |
| Rubbert, A | 1 |
3 other studies available for mirtazapine and Ambulation Disorders, Neurologic
| Article | Year |
|---|---|
Cardiac arrest induced by the intentional ingestion of boric acid and mirtazapine treated by percutaneous cardiopulmonary bypass: a case report.
Topics: Antidepressive Agents; Boric Acids; Cardiopulmonary Bypass; Depression; Disability Evaluation; Drug | 2019 |
Unsteady Gait and Dizziness.
Topics: Accidental Falls; Anticonvulsants; Cervical Cord; Clonazepam; Dizziness; Epidural Neoplasms; Gait Di | 2016 |
Longterm remission of more than 5 years in a patient with progressive multifocal leucoencephalopathy and sarcoidosis.
Topics: Anti-Inflammatory Agents; Antiviral Agents; Brain; Cidofovir; Cytosine; Female; Gait Disorders, Neur | 2012 |